|
Palo Alto, CA, April 22, 2004 — Telik, Inc. (Nasdaq:
TELK) announced that its quarterly conference call and webcast will
be held on Thursday, April 29, 2004 at 4:30 p.m. Eastern time (1:30
p.m. Pacific time). The call will follow the release of Telik’s
financial results for the first quarter ended March 31, 2004 earlier
that day.
Participants may access the live webcast via Telik’s website
at www.telik.com or by telephone at 303-262-3306. A replay of the
webcast will be available on the Telik website from approximately
8:30 p.m. Eastern time on April 29 through May 6, 2004.
Telik, Inc. of Palo Alto, CA is a biopharmaceutical company working
to discover, develop and commercialize small molecule drugs to treat
serious diseases for which there is significant demand for new therapies.
The company’s most advanced drug development candidate is
TELCYTA™. Telik’s product candidates were discovered
using its proprietary technology, TRAP, which enables the rapid
and efficient discovery of small molecule drug candidates. Additional
information is available at www.telik.com.
###
Contact:
Carol DeGuzman
Senior Director, Corporate Communications
Telik, Inc.
Tel 650-845-7728
Email cdeguzman@telik.com
Go to: 2004
Press Releases2003
Press ReleasesEvents
|
